HSP65 e imunorregulação na mucosa intestinal em modelo experimental de diabetes tipo 1
=== In previous studies by our group, we have shown that oral administration of Hsp65-producing Lactococcus lactis is a successful strategy to prevent the development of chronic inflammatory disease models such as ulcerative colitis and experimental autoimmune encephalomyelitis (EAE). This treatmen...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | Portuguese |
| Published: |
Universidade Federal de Minas Gerais
2014
|
| Online Access: | http://hdl.handle.net/1843/BUBD-9UVMHC |